Preface

The exponential expansion of nanotechnology and its intersection with conventional plant-derived medicine have portended a new age in therapeutic development. The edited book, NanoPhytomedicine: Unlocking Nature and Nanotechnology for Neurological and Metabolic Health, is a timely and comprehensive exploration of this interdisciplinary frontier. The primary objective of this book is to examine the synergistic potential of phytomedicine and nanotechnology in addressing the increasing global burden of neurological and metabolic disorders—two interrelated areas that continue to challenge modern healthcare systems. In this book, it is demonstrated that nanoformulations are capable of bypassing the limitations of traditional phytotherapy, such as low bioavailability, instability, and targeted delivery limitations, by merging the centuries-long proven efficacy of plant-derived drugs with the precision and effectiveness of nanoscale delivery systems.

This book addresses an overarching theme, from fundamental principles to emerging trends and translational applications of nano-enabled phytotherapeutics. It brings together leading researchers, clinicians, and scientists from across disciplines to contribute novel information, critical reviews, and recent advancements in design, synthesis, characterization, and application of nanophytomedicines. Particular emphasis is placed on their role in governing key molecular processes that are implicated in neurological diseases such as neurodegenerative diseases, depression, anxiety, epilepsy, myasthenia gravis, and stroke, and metabolic diseases such as diabetes, obesity, dyslipidemia, and hepatic disease. Overall, the chapters highlight the importance of pharmacokinetics, nanocarrier systems, green synthesis protocols, and regulatory aspects that are critical to producing safe and effective therapies.

In addition, this book tackles the existing challenges and future directions of applying nanophytomedicine in clinical settings. It examines the neurometabolic disorders of multifactorial etiology and shows how nanophytomedicines exert multifaceted modes of action, providing neuroprotection and regulating metabolic functions. The book further examines the relevance of sustainable and ethical extraction of phytochemicals, as well as the promise of personalized nanophytotherapy. The integration of case studies, preclinical observations, and translational insights adds relevance not only for researchers but also for clinicians, industry experts, and policymakers. Our aspiration is that this collection will spark new research avenues, facilitate interdisciplinary collaboration, and eventually lead towards the creation of useful, safe, and affordable therapeutics to address some of our most urgent health issues today.